Skip to main content
Premium Trial:

Request an Annual Quote

AbCellera: Andrew Booth, Tryn Stimart

AbCellera, a firm that levearges single-cell analysis technologies to discover and develop therapeutic antibodies, has named Andrew Booth as chief financial officer and Tryn Stimart as general counsel.

Booth joins AbCellera from Stemcell Technologies, where he held the roles of vice president of instrumentation, chief financial officer, and chief commercial officer. Prior to this he led mergers and acquisitions for GE Healthcare's Europe, Middle East, and Africa business and its global life sciences business.

Stimart joins AbCellera from law firm Gibbons PC, where he was a partner in the firm's New York office. Prior to this, he held positions as legal counsel at Finnegan LLP, Cooley LLP, and Womble Bond Dickinson LLP.

The Scan

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.

Researchers Retrace Key Mutations in Reassorted H1N1 Swine Flu Virus With Avian-Like Features

Mutations in the acidic polymerase-coding gene boost the pathogenicity and transmissibility of Eurasian avian-like H1N1 swine influenza viruses, a PNAS paper finds.

Genome Sequences Reveal Evolutionary History of South America's Canids

An analysis in PNAS of South American canid species' genomes offers a look at their evolutionary history, as well as their relationships and adaptations.

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.